An Israeli-German research team headed by Prof. Yaakov Nahmias from the Alexander Grass Center of Bioengineering at the Hebrew University in Jerusalem has developed an organ-on-a-chip model with a tiny human liver, which can be used longer than a month. Since they inserted additionally optoelectronic sensors into the cells, they were able to discover an important toxicity of acetaminophen.

The Hessian state government wants to contribute to the reduction of animal experiments with two new professorships and a reoccupation of a further professorship. At two locations - Frankfurt and Giessen - this project is supported with 2 million euros in the next five years.

DFG promotes lab-on-a-chip research group

Wednesday, 01 July 2015 11:07

In the next few years the Leipzig research group "Integrated chemical micro laboratories" will be supported with a research funding from the German Research Foundation (DFG).

immune2day is a new method for the detection of vaccines. The research group led by Dr. Günter Roth from Freiburg Centre for Biosystems Analysis has developed a copying machine for biomolecules that can copy DNA. In this manner they want detect potential vaccine candidates against pathogens in the shortest time.

Investigation of Nanoparticles in egg

Thursday, 25 June 2015 09:55

Jena scientists headed by Prof. Dr. Dagmar Fischer want to examine long-term effects which result from the uptake of nanoparticles in the body, e.g. caused by contrast agents. For this purpose they want to use cell cultures and an egg-model.

Newsletter January 2015

Tuesday, 23 June 2015 21:57

Scientists of Helmholtz Zentrum München have developed a 3D microtissue-based screening system which, for the first time, enables them to test which chemotherapeutic drugs can resensitize breast cancer cells to radiation.

A researcher team from Helmholtz Center Munich has developed a new in vitro model consisting of brain cells which can be used to study latent HIV infections of brain cells.

Scientists at IfADo - Leibniz Research Centre for Working Environment and Human Factors at the TU-Dortmund in cooperation with partners from all over Europe - have developed a method to genetically compare hepatocyte-like cells with real liver cells.

As an interdisciplinary association of about 70 expert groups from all over Germany the Virtual Liver Network (VLN) has worked from 2010 to this year´s March. As part of the modeling of complex liver processes the research group of Prof. Dr. Rolf Gebhardt, Professor of Biochemistry at the Faculty of Medicine of the University of Leipzig has identified a metabolism pathway which can be used to treat pathological fatty liver.